Circulatory and respiratory health in Canada
Open Access Government looks into the current research priorities and initiatives of Canada’s Institute of Circulatory and Respiratory Health (ICRH).
How are social media giants tackling misinformation during COVID-19?
Özlem Bedre-Defolie, Associate Professor of Economics at ESMT Berlin, reflects on how platforms like WhatsApp and Facebook are tackling misinformation at this crucial hour.
Encouraging astronomical sciences in the U.S.
Editor of Open Access Government, Jonathan Miles, takes us on a voyage of discovery when it comes to supporting astronomical sciences in the U.S.
Putting people first and strengthening the EU’s Economy
Here, Open Access Government looks into European Commissioner Paolo Gentiloni’s priorities for strengthening the EU’s Economy while also putting citizens first, particularly in a time of crisis.
Type 2 diabetes and heart failure creates highest death risk
Those newly diagnosed with Type 2 diabetes and heart failure are at the greatest 5-year risk of death, according to scientists at The American Heart Association.
Artificial beta cells could lead to new diabetes treatment
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
Battery research using calorimeters: Improving thermal management and safety
Dr Carlos Ziebert, Head of IAM-AWP’s Calorimeter Center, KIT, presents a holistic approach to how battery calorimeters can be applied all along the battery value chain.
What are the UK’s priorities for energy policy including electric vehicles today?
Megan Warrender of Open Access Government explores Department for Business, Energy, and Industrial Strategy, led by Rt Hon Alok Sharma MP’s, priorities for energy policy in response to COVID-19.
Greenheart CBD: A green crop from seed to shelf
Here, we learn how about a different kind of green crop that grows in Ireland and the journey of that from seed to shelf as part of the Greenheart CBD story.
REMADYL: Removal of Legacy Substances from polyvinylchloride (PVC)
Manager EU Research at Centexbel, Guy Buyle introduces REMADYL, a H2020 project focused on the removal of legacy substances from PVC via a continuous and sustainable extrusion process.
A Europe fit for the digital age
The strides being made by the European Commission to achieve a digitalised society for all are explored by Assistant Editor of Open Access Government, Megan Warrender.
How will COVID-19 reframe our attitude towards AI ethics?
Vernon Hunte, Associate Director of Public Affairs at April Six, discusses how COVID-19 will change up out attitude towards artificial intelligence (AI) ethics.
Reactive laser ablation in liquid: A route to novel nanocomposites
Here, Katharine Moore Tibbetts explores laser ablation in liquid as a versatile synthetic technique.
Racism in the workplace: A view from the United States
In the first of two articles, the US member firm of Ius Laboris, provides suggestions on actions employers in the United States should reinforce against racism and discrimination in the workplace.
5 simple ways to meet new workplace safety standards
Lee Hatwell, director of Munday + Cramer, addresses some of the most frequently asked questions regarding what simple measures can be taken to meet new Government safety standards and ease employee anxieties towards returning to work.
Handling the healthcare impact of COVID-19
Sue Johnson Gregory, principal consultant, and Tim Powlson, senior consultant, at Entec Si, discuss how the NHS can recover from the long-term impact of COVID-19.
Battery technologies underpin green recovery plans in Europe
Dr Alistair Davidson, Director of the Consortium for Battery Innovation, argues that battery technologies underpin green recovery plans in Europe.
Attracting major investors: GreenLight on the international stage
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
Time to take a lead by taking lead out of the environment
Jacques Trouvilliez, Executive Secretary of AEWA, discusses the challenge of continued use of lead ammunition.
The medical cannabis space: A successful targeted investment strategy
In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.
